Markets
Alerts
F&O
MF
Reports
Screeners
Subscribe
Superstars
Portfolio
Watchlist
Insider Trades
Results
Data Downloader
Events Calendar
What's New
Explore
FAQs
All Features
Widgets
More
Search stocks
IND
USA
IND
IND
×
Close
IND
USA
Stocks
Futures & Options
Mutual Funds
News
Fundamentals
Reports
Corporate Actions
Alerts
Shareholding
Overview
Buy Sell Zone
F&O
Financials
News
All
News
Earnings Calls
Corporate Announcements
Research Reports
Reports
Technicals
Technicals
Price History/Seasonality
Delivery
Shareholding
Shareholding
Monthly MF Holdings
Bulk Block Deals
Insider Trading & SAST
Deals
Bulk Block Deals
Insider Trading & SAST
Corporate Actions
All
Dividend
Bonus
Split
Rights
Board Meetings
Alerts
About
Dr. Reddy's Laboratories Ltd.
NSE: DRREDDY
|
BSE: 500124
|
ISIN: INE089A01031
|
Industry: Pharmaceuticals
|
Mid-range Performer
1191.2000
-24.30
(
-2.00
%)
NSE
Jan 13, 2026
15:14 PM
Volume:
1.9M
Share on Facebook
Tweet
Share on LinkedIn
Share via Whatsapp
Dr. Reddy's Laboratories Ltd.
29 Jun 2022
1191.20
-2.00%
Company Update:Dr Reddys Labs
Buy:
Dr. Reddy's Laboratories Ltd.
by
Axis Direct
Target: 4750
Target
Axis Direct
We recommend a BUY rating on the stock with a TP of Rs 4,750.
Dr. Reddy's Laborato.. has an
average target
of 1281.89 from 9 brokers.
More from Dr. Reddy's Laboratories Ltd.
Recommended
Market trades lower, ICICI Prudential Life Insurance's net profit grows 19% YoY in Q3
Trendlyne Marketwatch |
13 Jan 2026, 02:52PM
IPO wave continues as Amagi Media and Five SMEs open for subscription
|
12 Jan 2026, 06:40PM
Dr Reddy’s Labs struggles in its biggest market
|
18 Aug 2021